Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Mechanisms of Covid-19 Entry Into the Cell: Potential Therapeutic Approaches Based on Virus Entry Inhibition in Covid-19 Patients With Underlying Diseases Publisher Pubmed



Musavi H1 ; Abazari O2 ; Safaee MS3 ; Variji A4 ; Koohshekan B4 ; Kalakijouybari F1 ; Barartabar Z5 ; Hakemi P6 ; Mahjoub S7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Biochemistry, School of Medicine, Babol University of Medical Sciences, Babol, Iran
  2. 2. Department of Clinical Biochemistry, School of Medicine, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran
  3. 3. Department of Biology, Faculty of Biology Sciences, Islamic Azad University, North Tehran Branch, Tehran, Iran
  4. 4. Department of Clinical Biochemistry, Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Department of Clinical Biochemistry, School of Medicine, Hamedan University of Medical Sciences, Iran
  6. 6. Department of Chemical Engineering, Islamic Azad University, Ayatollah Amoli Branch, Amol, Iran
  7. 7. Department of Clinical Biochemistry, School of Medicine, Babol University of Medical Sciences, Babol, Iran AND Cellular, and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran AND Department of Pathology, University of Kiel, Kiel, Germany

Source: Iranian journal of allergy, asthma, and immunology Published:2021


Abstract

The Coronavirus disease 2019 (COVID-19) virus spread from Wuhan, China, in 2019 and is spreading rapidly around the world. COVID-19 victims are almost associated with cardiovascular disease, high blood pressure, diabetes, and other underlying diseases. Concerning the high prevalence of these disorders, widespread mortality threatens global society, and its fatality rate may increase with increasing COVID-19 prevalence in countries with older populations. Therefore, evaluating patients' clinical status with severe COVID-19 infection and their medical history can help manage treatment. Currently, one of the considered treatments is angiotensin-converting enzyme 2 (ACE2) inhibition. This study investigated virus entry mechanisms through membrane receptors, their role in the pathogenesis of COVID-19 and underlying diseases, and treatment methods based on the viral entrance inhibition. According to existing studies, inhibition of ACE2 can increase oxidative stress, inflammation, fibrosis and ultimately exacerbate underlying diseases such as cardiovascular disease, kidney disease, diabetes, and hypertension in individuals with COVID-19. The ACE2 inhibition is not suitable for patients with COVID-19 with underlying diseases, but it seems that the recombinant ACE2 solution is more appropriate for inhibiting the virus in these patients if hypotension would be monitored.
Related Docs
View other Related Docs
1. Gastrointestinal and Kidney Manifestations in Sarscov and Sars-Cov-2 Infections: Role of Angiotensin-Converting Enzyme 2, Physiology and Pharmacology (Iran) (2021)
2. Association of Rasis and Hmg-Coa Reductase Inhibitors With Clinical Manifestations in Coronavirus Disease 2019 Patients: Results From the Khorshid Coronavirus Disease Cohort Study, Journal of Research in Medical Sciences (2023)
3. Hypotheses for Reactivation Recurrence and Reinfection Recurrence of Covid-19, Applied Biological Research (2021)
4. Comprehensive Overview of Covid-19-Related Respiratory Failure: Focus on Cellular Interactions, Cellular and Molecular Biology Letters (2022)
5. Drug Repurposing Against Angiotensin-Converting Enzyme-Related Carboxypeptidase (Ace2) Through Computational Approach, Journal of Medical Signals and Sensors (2022)
6. In Silico Investigation of Critical Binding Pattern in Sars-Cov-2 Spike Protein With Angiotensin-Converting Enzyme 2, Scientific Reports (2021)
7. The Favorable Impacts of Silibinin Polyphenols As Adjunctive Therapy in Reducing the Complications of Covid-19: A Review of Research Evidence and Underlying Mechanisms, Biomedicine and Pharmacotherapy (2022)
8. High Prevalence of Sars-Coronavirus-2 in Patients With Inflammatory Bowel Disease and the Role of Soluble Angiotensin Converting Enzyme2, Archives of Physiology and Biochemistry (2024)
Experts (# of related papers)
View all Related Experts
Shahrzad Ahangarzadeh (4)
Hamid Bakherad (2)
Other Related Docs
9. Treatment of Covid-19 With Pentoxifylline: Could It Be a Potential Adjuvant Therapy?, Dermatologic Therapy (2020)
10. Utilization of Sumo Tag and Freeze-Thawing Method for a High-Level Expression and Solubilization of Recombinant Human Angiotensin-Converting Enzyme 2 (Rhace2) Protein in E. Coli, Protein and Peptide Letters (2022)
11. Epidemiology, Virology, Clinical Features, Diagnosis, and Treatment of Sars-Cov-2 Infection, Journal of Experimental and Clinical Medicine (Turkey) (2021)
12. Thrombotic Storm in Coronavirus Disease 2019: From Underlying Mechanisms to Its Management, Journal of Medical Microbiology (2022)
13. Supplementation With Vitamin D in the Covid-19 Pandemic?, Nutrition Reviews (2021)
14. Current Status of Covid-19 Pandemic; Characteristics, Diagnosis, Prevention, and Treatment, Journal of Research in Medical Sciences (2020)
15. Coenzyme Q10 and Its Therapeutic Potencies Against Covid-19 and Other Similar Infections: A Molecular Review, Advanced Pharmaceutical Bulletin (2023)
16. A Narrative Literature Review on Traditional Medicine Options for Treatment of Corona Virus Disease 2019 (Covid-19), Complementary Therapies in Clinical Practice (2020)
17. Pi3k/Akt/Mtor Pathway: A Potential Target for Anti-Sars-Cov-2 Therapy, Immunologic Research (2022)
18. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
19. Antiviral Mechanisms of Curcumin and Its Derivatives in Prevention and Treatment of Covid-19: A Review, Advances in Experimental Medicine and Biology (2023)
20. A Study on the Effect of Aspirin on Clinical Symptoms, Laboratory Indices, and Outcomes in Patients With Covid-19, Journal of Nephropharmacology (2023)
21. Computational Design of a Potential Therapeutic Peptide Against Spike Protein of Sars-Cov-2, Journal of Computational Biophysics and Chemistry (2021)
22. Using in Silico Bioinformatics Algorithms for the Accurate Prediction of the Impact of Spike Protein Mutations on the Pathogenicity, Stability, and Functionality of the Sars-Cov-2 Virus and Analysis of Potential Therapeutic Targets, Biochemical Genetics (2023)
23. Cardiovascular Complications of Sars-Cov-2 Vaccines: An Overview, Cardiology and Therapy (2022)
24. Herbal Medicines As Potential Inhibitors of Sars-Cov-2 Infection, Current Pharmaceutical Design (2022)
25. Recent Findings of Coronavirus: The Pathogenesis and Treatment, Journal of Isfahan Medical School (2020)
26. Therapeutic Targets of Natural Products for the Management of Cardiovascular Symptoms of Coronavirus Disease 2019, Phytotherapy Research (2021)
27. Evaluation of Angiotensin Converting Enzyme 2 (Ace2), Angiotensin Ii (Ang Ii), Mir-141-3P, and Mir-421 Levels in Sars-Cov-2 Patients: A Case-Control Study, BMC Infectious Diseases (2024)
28. Emerging Technologies for the Treatment of Covid-19, Advances in Experimental Medicine and Biology (2021)
29. N-Acetylcysteine and Coronavirus Disease 2019: May It Work As a Beneficial Preventive and Adjuvant Therapy? a Comprehensive Review Study, Journal of Research in Medical Sciences (2020)
30. The Role of N-Acetyl Cysteine and Some Other Clinical Antidotes in the Treatment of Patients With Covid-19; Review of the Current Evidence, Immunopathologia Persa (2023)
31. Tnf-Α Blockers Showed Prophylactic Effects in Preventing Covid-19 in Patients With Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case–Control Study, Rheumatology and Therapy (2021)
32. Potential Inhibitors of Sars-Cov-2: Recent Advances, Journal of Drug Targeting (2021)
33. Correlation of Expression of Mmp-2, Ace2, and Tmprss2 Genes With Lymphopenia for Mild and Severity of Covid-19, Iranian Journal of Allergy, Asthma and Immunology (2023)
34. Bioinformatic Screening of Compounds From Iranian Lamiaceae Family Members Against Sars-Cov-2 Spike Protein, Letters in Drug Design and Discovery (2023)
35. Human Microbiome in Post-Acute Covid-19 Syndrome (Pacs), Current Research in Microbial Sciences (2025)
36. Different Aspects in Explaining How Mutations Could Affect the Binding Mechanism of Receptor Binding Domain of Sars-Cov-2 Spike Protein in Interaction With Ace2, PLoS ONE (2023)
37. Sars-Cov-2, Sars and Mers: Three Formidable Coronaviruses Which Have Originated From Bats; [Sars-Cov-2, Sars-Cov I Mers-Cov: Trzy Grozne Koronawirusy Pochodzace Od Nietoperzy], Postepy Higieny i Medycyny Doswiadczalnej (2021)
38. An Overview on Acute Kidney Injury Following Covid-19, Journal of Parathyroid Disease (2023)
39. Investigating Methods for Coronavirus Disease 2019 Control: A Systematic Review, Polish Annals of Medicine (2021)
40. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
41. New Treatments (Msc) in Immune Disorders Like Cancers and Covid Infection: Cancer and Virus New Treatment (Msc), Asia Pacific Journal of Cancer Biology (2024)
42. Potential Treatments for Covid-19; a Narrative Literature Review, Archives of Academic Emergency Medicine (2020)
43. Mesenchymal Stem Cells: A Potent Cell Source for Covid-19, Coronaviruses (2021)
44. The Molecular Basis of Covid-19 Pathogenesis, Conventional and Nanomedicine Therapy, International Journal of Molecular Sciences (2021)
45. Covid-19 Prevention and Treatment by Targeting Proteins: An Experience to Fight Emerging Diseases, Current Molecular Medicine (2024)